Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

NCT04375813 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

166

Enrollment

OTHER

Sponsor class

Conditions

Non-muscle Invasive Bladder Cancer

Interventions

DRUG: eRapa
DRUG: Placebos

Sponsor

Robert Svatek

Collaborators

[object Object]